[Osteoporosis and prolonged administration of antialdosterone drugs. Histomorphometric study].
D000328:Adult; D002112:Calcifediol / Q000627:therapeutic use; D002118:Calcium / Q000627:therapeutic use; D004334:Drug Administration Schedule; D005260:Female; D005598:Fractures, Spontaneous / Q000000981:diagnostic imaging; D006801:Humans; D006929:Hyperaldosteronism / Q000188:drug therapy; D010024:Osteoporosis / Q000139:chemically induced* / Q000188:drug therapy / Q000473:pathology; D011859:Radiography; D012969:Sodium Fluoride / Q000627:therapeutic use; D013124:Spinal Injuries / Q000000981:diagnostic imaging; D013148:Spironolactone / Q000009:adverse effects* / Q000627:therapeutic use; D013997:Time Factors
D013148:Spironolactone; D012969:Sodium Fluoride; D002112:Calcifediol; D002118:Calcium
Ostéoporose et prise prolongée d'antialdostérone. Une observation avec étude histomorphométrique.